Connor, Clark & Lunn Investment Management (CC&L)’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
SLG
PTC
Connor, Clark & Lunn Investment Management (CC&L)'s GDRX Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 241,548 shares — an estimated $473K sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GDRX in Q4 2022 and held it in 14 quarters. The position peaked at $8.32M in Q2 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 241,548 GoodRx Holdings shares in Q2 2026, an estimated $473K.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GoodRx Holdings in Q4 2022 and held it in 14 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s GoodRx Holdings position peaked at $8.32M in Q2 2025.
- 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.